Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever

Profectus Biosciences, Inc., Baltimore MD

Investigators

Abstract

To support the advanced development of multivalent vaccine candidates for filoviruses and Lassa Fever. This contract aims to formulate a multivalent vaccine that provides protection against several pathogens, including Ebola virus, Marburg virus and Lassa Fever. It may support cGMP manufacture of a stable lyophilized vaccine formulation and preparation and submission of an IND to support eventual clinical evaluation.